Original language | English |
---|---|
Pages (from-to) | 468-471 |
Number of pages | 4 |
Journal | The Lancet Psychiatry |
Volume | 7 |
Issue number | 6 |
DOIs |
|
Publication status | Published - 1 Jun 2020 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Suicide risk and prevention during the COVID-19 pandemic. / COVID-19 Suicide Prevention Research Collaboration.
In: The Lancet Psychiatry, Vol. 7, No. 6, 01.06.2020, p. 468-471.Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - Suicide risk and prevention during the COVID-19 pandemic
AU - COVID-19 Suicide Prevention Research Collaboration
AU - Gunnell, D
AU - Appleby, Louis
AU - Arensman, Ella
AU - Hawton, K
AU - John, Anne
AU - Kapur, Nav
AU - Khan, M
AU - O'Connor, R C
AU - Pirkis, J
N1 - Funding Information: Affiliations of the International COVID-19 Suicide Prevention Research Collaboration are listed in the appendix . The views and recommendations in this Comment are endorsed by the International Association of Suicide Prevention, the American Foundation for Suicide Prevention, and the International Academy of Suicide Research. DG, KH, and NK are members of the Department of Health and Social Care (England) National Suicide Prevention Strategy Advisory Group; LA is the chair. DG has grants from the National Institute for Health Research (NIHR) outside the submitted work, and is a member of Samaritans Policy and Research Committee and Movember's Global Advisory Committee. LA and KH hold grants from the Department of Health and Social Care during the conduct of this work. AJ reports chairing the National Advisory Group on Suicide and Self-harm Prevention to Welsh Government and is national lead on suicide prevention for Public Health Wales. NK reports grants and personal fees from the Department of Health and Social Care, NIHR, National Institute of Health and Care Excellence (NICE), and Healthcare Quality and Improvement Partnership, outside the submitted work, and works with NHS England on national quality improvement. He has chaired NICE guideline committees for self-harm and depression and is currently the topic advisor for the new NICE guidelines for self-harm. RCO'C reports grants from NIHR, Medical Research Foundation, Scottish Government, NHS Health Scotland, and Public Health Scotland, outside the submitted work. He is also co-chair of the Academic Advisory Group to the Scottish Government's National Suicide Prevention Leadership Group, and a member of NICE's guideline development group for the new NICE guidelines for suicide and self-harm. All other authors declare no competing interests. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6/1
Y1 - 2020/6/1
UR - https://doi.org/10.1016/S2215-0366(20)30171-1
U2 - 10.1016/S2215-0366(20)30171-1
DO - 10.1016/S2215-0366(20)30171-1
M3 - Comment/debate
VL - 7
SP - 468
EP - 471
JO - The Lancet Psychiatry
JF - The Lancet Psychiatry
SN - 2215-0366
IS - 6
ER -